Log In
BCIQ
Print this Print this
 

Biosimilar imiglucerase (GNR-008)

  Manage Alerts
Collapse Summary General Information
Company International Biotech Center Generium (IBC Generium)
DescriptionBiosimilar of imiglucerase, a recombinant DNA-produced analogue of human beta-glucocerebrosidase
Molecular Target
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationGaucher's disease
Indication DetailsTreat Gaucher's disease Type I
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today